rheumatology
Autoinflammatory diseases

PMR triggered by immunotherapy may require lower doses of prednisolone

Polymyalgia rheumatica (PMR) that is triggered by immune checkpoint therapy can be treated with lower doses of prednisolone – between 5 mg to 7.5 mg per day –  than is currently recommended by guidelines to treat regular PMR, clinicians state. Writing in the Annals of the Rheumatic Diseases, the rheumatologists from the Netherlands say their ...

Already a member?

Login to keep reading.


OR
© 2020 the limbic